BRUSSELS (REUTERS) - A World Health Organisation-led programme to ensure poorer countries get fair access to Covid-19 vaccines, tests and treatments aims to secure antiviral drugs for patients with mild symptoms for as little as US$10 (S$13.50) per course, a draft document seen by Reuters says. Merck & Co's experimental pill molnupiravir is likely to be […]

Read more of this post


This free site is ad-supported. Learn more